--- title: What treatments work for PMDD? | Niyora description: SSRIs (a type of antidepressant) and certain types of birth control are the main first-line treatments. New treatments targeting brain chemistry are being dev url: https://niyora.com/research/papers/premenstrual-dysphoric-disorder-pmdd-current-pharmacotherapy-and-emerging-2026/ --- - [Niyora](https://niyora.com/) - [Research](https://niyora.com/research/) - [Library](https://niyora.com/research/library/) - What treatments work for PMDD? Study, 2026 # What treatments work for PMDD? SSRIs (a type of antidepressant) and certain types of birth control are the main first-line treatments. New treatments targeting brain chemistry are being developed. Moderate study design Review of published research on PMDD treatment ## What they did Researchers reviewed published research on current and emerging treatments for PMDD, including antidepressants, hormone-based birth control, and new approaches in development. ## What they found SSRIs like sertraline, fluoxetine, paroxetine, and escitalopram work well for PMDD. They can be taken continuously or just during the luteal phase (the week before your period), often at low doses, and often bring rapid relief. Certain birth control pills and other hormone treatments can reduce symptoms by stopping ovulation. New treatments being studied include sepranolone and other medications targeting brain chemistry and inflammation. ## What it means for you If you have PMDD, SSRIs and hormone birth control are proven treatments. Your doctor can discuss which approach fits best for you. Many newer treatments are in development, so more options may become available. This is a review of existing evidence, not new research findings. ## About the study Original title PREMENSTRUAL DYSPHORIC DISORDER (PMDD): CURRENT PHARMACOTHERAPY AND EMERGING TREATMENT APPROACHES Authors Julia Oziębło, Magdalena Kijowska, Karolina Klusek et al. Journal International Journal of Innovative Technologies in Social Science Year 2026 Study design Study What was tested None Open access Yes Read the paper [doi.org/10.31435/ijitss.3(51).2026.6100](https://doi.org/10.31435/ijitss.3(51).2026.6100) Original abstract Premenstrual dysphoric disorder (PMDD) is a cyclic mood disorder affecting a subset of women in the late luteal phase, marked by severe affective and physical symptoms that resolve with menses. It is distinguished from milder premenstrual syndrome (PMS) by symptom severity and functional impairment. PMDD causes substantial distress: women with PMDD have functional impairments comparable to other depressive disorders and increased work absences, and PMDD is associated with higher rates of suicidal ideation and attempts. First-line pharmacotherapy consists of selective serotonin reuptake inhibitors (SSRIs) and hormone-based treatments. SSRIs (e.g. sertraline, fluoxetine, paroxetine, escitalopram) are effective when dosed continuously or in the luteal phase, often producing rapid symptom relief at low doses. Hormonal therapies (e.g. combined oral contraceptives with drospirenone/ethinyl estradiol, GnRH agonists with add-back) can mitigate symptoms by suppressing cyclic ovarian hormone fluctuations. Emerging treatments target PMDD’s neuroendocrine underpinnings: for example, sepranolone (an allopregnanolone antagonist) has shown promising early results. Novel approaches under investigation include neurosteroid modulators, anti-inflammatory strategies, and personalized interventions (genetic or biomarker-driven therapy). This review summarizes current evidence-based pharmacotherapies for PMDD and discusses emerging treatment avenues based on advances in PMDD neurobiology and psychoneuroendocrinology. Reproduced under CC-BY. ## Topics [Premenstrual syndrome (PMS)](https://niyora.com/research/topics/condition-pms/)[Premenstrual dysphoric disorder (PMDD)](https://niyora.com/research/topics/condition-pmdd/)[Menstrual cycle and mood](https://niyora.com/research/topics/condition-cycle-mood/)[Low mood and depression](https://niyora.com/research/topics/symptom-depression-mood/)[SSRIs and antidepressants](https://niyora.com/research/topics/treatment-ssri/)[Oral contraceptives and drospirenone](https://niyora.com/research/topics/treatment-hormonal-contraceptives/)[GnRH agonists and ovarian suppression](https://niyora.com/research/topics/treatment-gnrh/)[Neurosteroids (allopregnanolone)](https://niyora.com/research/topics/treatment-neurosteroids/)[Major depressive disorder](https://niyora.com/research/topics/comorbidity-major-depression/)[Quality of life and daily functioning](https://niyora.com/research/topics/life-area-quality-of-life/) Research tells you what helps on average. Niyora helps on the day it hits. Calm down, see it another way, and decide what to say, with a PMS and PMDD app built by a doctor. ## Related studies Case report, 2023 Can stopping ovulation help severe PMDD when other treatments do not work? Study, 2022 What are the symptoms, causes, and treatments of PMS and PMDD? Study, 2008 How common is PMDD and how does it affect women's lives? Cohort study, 2022 What are PMS and PMDD and how should they be diagnosed and treated? Randomised trial, 2017 Does Sepranolone reduce symptoms of severe premenstrual syndrome (PMDD)? Systematic review, 2024 What are the best treatments for PMDD and PMS? Ask AI about this page Copy prompt ChatGPT ↗ Claude ↗ Perplexity ↗ Google AI Mode ↗ Grok ↗